Loading viewer...
annual_report
Format: PDF annual_report
Alkem Laboratories Limited's 50th Annual Report for FY 2024 (ended March 31) details consolidated and standalone financial performance with 7.9% revenue growth and 54% net profit increase. The report covers operational highlights, dividend distributions, subsidiary information, and corporate governance compliance.
ACADIA Pharmaceuticals 2020 Proxy Statement Annual Meeting
annual_reportannual_report
74 Pages
ACADIA Pharmaceuticals
annual_report
Conn’s
Alkem Laboratories 2017-18 Annual Report
annual_reportannual_report
236 Pages
Mogo
Adaptimmune Therapeutics 2024 Annual Report 10-K
annual_reportannual_report
167 Pages
Adaptimmune Therapeutics
annual_report
Enzo Biochem
annual_report
ENI SpA